The Valley Desk

ArticleMolecular therapy. AdvancesPublished

Epitope mapping of humoral immunogenicity of orvacabtagene autoleucel shows an IgM response with minimal impact on CAR T cellular kinetics

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Molecular therapy. Advances
Published
Subject terms
Multiple myeloma; Cellular Kinetics; Car T Cell; B Cell Epitope Mapping; Orvacabtagene Autoleucel; Anti-therapeutic Antibodies; Igm Isotype; Humoral Immunogenicity
PubMed ID
42375474
PubMed Central ID
PMC13312103
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal